Obalon Therapeutics, Inc. OBLN
$ 3.05
-5.86%
Obalon Therapeutics, Inc. Balance Sheet 2011-2024 | OBLN
Annual Balance Sheet Obalon Therapeutics, Inc.
2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
6.46 M | -12.9 M | -11.3 M | -11.2 M | -60.6 M | 6.48 M | -2.02 M | - | - | - |
Long Term Debt |
430 K | - | - | 7.96 M | 9.88 M | 9.09 M | 4.88 M | - | - | - |
Total Non Current Liabilities |
906 K | 567 K | 48 K | 7.98 M | 9.88 M | 63.8 M | 59.7 M | - | - | - |
Total Current Liabilities |
5.05 M | 3.98 M | 17.2 M | 10 M | 4.59 M | 5.57 M | 872 K | - | - | - |
Total Liabilities |
5.95 M | 4.54 M | 17.3 M | 18 M | 14.5 M | 69.4 M | 60.6 M | - | - | - |
Deferred Revenue |
- | 424 K | 352 K | 510 K | - | - | - | - | - | - |
Retained Earnings |
-185 M | -172 M | -149 M | -111 M | -76.6 M | -56.1 M | -40.6 M | - | - | - |
Total Assets |
10.6 M | 20.4 M | 30.4 M | 53.1 M | 78.8 M | 14.2 M | 20.7 M | - | - | - |
All numbers in USD currency